Collegium Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Collegium Pharma (COLL) Misses Q1 EPS by $1.29
May 10, 2022 5:04 PM EDTCollegium Pharma (NASDAQ: COLL) reported Q1 EPS of ($0.39), $1.29 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $83.8 million versus the consensus estimate of $78.88 million.
GUIDANCE:
Collegium Pharma sees FY2022 revenue of $450-465 million.
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
... More


